0
Pulmonary Procedures |

The Utility of Rapid On-Site Evaluation (ROSE) in the Detection of Granulomas in Mediastinal Lymph Nodes

Joseph Cicenia, MD; Francisco Almeida, MD; Michael Machuzak, MD; Peter Mazzone, MD; Atul Mehta, MD; Sonali Sethi, MD; Jinesh Patel, MD; Thomas Gildea, MD
Author and Funding Information

Cleveland Clinic, Cleveland, OH


Chest. 2013;144(4_MeetingAbstracts):797A. doi:10.1378/chest.1705246
Text Size: A A A
Published online

Abstract

SESSION TITLE: Bronchoscopy and Interventional Procedures Posters I

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM

PURPOSE: Rapid on-site evaluation (ROSE) of cytology samples serves several purposes: to determine sample adequacy and to triage subsequent samples for further testing. Although data regarding the efficacy of ROSE to impact the number of samples or diagnostic yield is contradictory, most of this data is in the area of malignant disease, specifically mediastinal staging in lung cancer. Furthermore, there has been little data on the utility of ROSE in benign mediastinal diseases such as sarcoidosis or histoplasmosis. It was our intent to retrospectively evaluate the utility of ROSE in mediastinal granulomatous disease, and whether it could impact bronchoscopic diagnosis of granulomatous lung disease.

METHODS: We retrospectively analyzed all patients with a cytologic diagnosis of granuloma made from EBUS-TBNA samples during a nine-month period from July 2012 to March 2013. Preliminary ROSE findings were compared with final cytologic diagnoses. Number of nodal stations biopsied per patient, number of passes per node, and concordance rates within nodes and patients were recorded and analyzed.

RESULTS: There were 218 nodes sampled in 81 patients. An average of 2.7 nodes were sampled per patient, and the median number of biopsy attempts per node was 3. Overall there were 37 nodes (17%) in which ROSE findings were discordant with their corresponding final diagnosis; in all the discordant samples the ROSE findings were negative and the final diagnosis demonstrated granulomas. There were 6 patients (7.4%) in which ROSE was negative in all nodal stations while the final cytology demonstrated granulomas in at least one of those nodal stations.

CONCLUSIONS: The use of ROSE in EBUS-TBNA for the detection of granulomas in mediastinal lymph nodes has a high concordance rate with the final diagnosis. When more than one lymph node is adequately sampled, sensitivity of ROSE for detection of granulomas in a patient is 93% and specificity is 100%.

CLINICAL IMPLICATIONS: Use of ROSE during EBUS-TBNA in which the final diagnosis is granuloma has a high concordance rate with the final diagnosis. This may prevent unnecessary transbronchial biopsies, especially when sarcoidosis is in the differential diagnosis.

DISCLOSURE: The following authors have nothing to disclose: Joseph Cicenia, Francisco Almeida, Michael Machuzak, Peter Mazzone, Atul Mehta, Sonali Sethi, Jinesh Patel, Thomas Gildea

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543